Aelix Therapeutics' Multi-Vector Therapeutic HIV Vaccine Could Be Backbone Of Combination Strategy

Clinical Studies Underway

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.